background
adequ
laboratori
diagnosi
human
rhinovirus
hrv
human
metapneumovirus
hmpv
requir
molecular
method
viral
cultur
lack
sensit
howev
set
individu
pcr
respiratori
virus
practic
preferenti
multiplex
pcr
use
object
develop
routin
diagnosi
rapid
realtim
pcr
assay
detect
hrv
hmpv
includ
intern
control
singl
tube
multiplex
reaction
use
probe
carri
differ
fluorophor
discrimin
target
studi
design
multiplex
realtim
rna
pcr
optim
includ
intern
control
viru
total
respiratori
sampl
patient
taken
oneyear
period
analyz
multiplex
assay
result
multiplex
assay
coamplif
intern
control
sensit
specif
individu
assay
applic
assay
clinic
sampl
patient
oneyear
period
result
incid
hrv
hmpv
respect
inhibit
defin
poor
intern
control
amplif
detect
sampl
cultur
perform
sampl
four
hrv
detect
conclus
realtim
pcr
method
enabl
sensit
diagnosi
two
respiratori
pathogen
potenti
expand
assay
part
full
molecular
respiratori
viral
screen
acut
upper
respiratori
tract
infect
urti
widespread
type
acut
infect
two
common
caus
urti
human
rhinoviru
hrv
human
metapneumoviru
hmpv
account
approxim
urti
respect
steining
et
al
kahn
howev
hrv
hmpv
also
caus
lower
respiratori
tract
lrt
symptom
sever
bronchiol
pneumonia
van
den
hoogen
et
al
falsey
et
al
detect
virus
nonoptim
convent
cell
cultur
slowgrowth
hmpv
one
reason
late
discoveri
viru
osterhau
fouchier
accur
diagnosi
hrv
hmpv
requir
molecular
method
van
den
hoogen
et
al
blomqvist
et
al
boivin
et
al
peret
et
al
stockton
et
al
vicent
et
al
pcr
describ
detect
hmpv
hrv
design
identifi
viru
individu
pcr
either
time
consum
requir
post
pcr
analysi
costli
requir
two
pcr
reaction
one
benefit
realtim
pcr
amplif
multiplex
probe
carri
differ
fluorophor
enabl
see
front
matter
elsevi
bv
right
reserv
differenti
amplifi
product
also
result
save
time
money
date
hmpv
multiplex
applic
describ
use
pcr
diagnost
tool
adequ
control
includ
ensur
integr
assay
monitor
rna
isol
inhibit
sampl
achiev
spike
clinic
sampl
known
amount
nonhuman
viru
niester
intern
control
coextract
coamplifi
reaction
result
fix
cycl
threshold
ct
valu
realtim
pcr
properli
isol
uninhibit
sampl
obvious
spike
reaction
design
way
pcr
multiplex
affect
way
neg
result
gener
greater
confid
purpos
studi
develop
multiplex
realtim
pcr
hmpv
hrv
intern
control
would
provid
rapid
sensit
specif
test
suffici
control
use
diagnosi
virus
addit
preval
clinic
signific
virus
assess
respiratori
sampl
taken
patient
decemb
decemb
hmpv
cultur
rhesu
monkey
kidney
cell
hrv
hrv
type
laboratori
isol
human
epidermoid
larynx
carcinoma
hel
cell
tenfold
dilut
seri
viru
stock
cultur
duplic
plate
centrifug
min
g
incub
co
hmpv
c
hrv
c
day
tissu
cultur
infect
dose
tcid
presenc
cytopath
effect
cpe
determin
aliquot
store
pcr
optimis
addit
subtyp
hrv
cultur
well
equin
arter
viru
eav
bucyru
strain
use
intern
control
cultur
babi
hamster
kidney
cell
c
stock
contain
plaqu
form
unitsml
respiratori
specimen
consist
sampl
submit
convent
routin
diagnosi
respiratori
virus
decemb
decemb
total
sampl
collect
patient
immunocompromis
immunocompet
specimen
collect
nasal
swab
throat
wash
bronchial
alveolar
lavag
bal
sputa
aliquot
specimen
store
c
prior
nucleic
acid
isol
pcr
cultur
perform
inocul
epidermoid
larynx
carcinoma
hel
cell
clinic
sampl
approxim
l
sampl
inocul
onto
celllin
shell
vial
shell
vial
centrifug
g
min
one
hel
shell
vial
incub
c
c
incub
c
shell
vial
incub
day
examin
daili
cytopath
effect
immunofluoresc
commerci
monoclon
antibodi
influenza
influenza
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
adenovirus
confirm
posit
cytopath
effect
dako
diagnost
glostrup
denmark
rhinovirus
distinguish
enterovirus
mean
acidl
test
panel
respiratori
virus
bacteria
commonli
found
respiratori
tract
use
determin
specif
multiplex
rnapcr
nucleic
acid
extract
influenza
influenza
b
rsv
adenoviru
type
coronaviru
develop
optimis
multiplex
rnapcr
rna
hmpv
hrv
posit
materi
extract
cell
cultur
supernat
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
magna
pure
lc
system
roch
appli
scienc
penzberg
germani
use
extract
nucleic
acid
clinic
specimen
assess
autom
extract
routin
diagnosi
primer
probe
sequenc
select
l
gene
sequenc
hmpv
van
den
hoogen
et
al
noncod
region
hrv
replicas
polyprotein
gene
eav
first
step
design
pcr
perform
align
ensur
select
conserv
region
within
target
primer
probe
interact
check
use
beacon
design
use
access
hmpv
hrv
eav
premier
biosoft
intern
palo
alto
usa
blast
search
perform
check
specif
stem
structur
molecular
beacon
italicis
report
dye
hexachlorofluorescein
hex
carboxyfluorescein
fam
indodicarbocyanin
quencher
black
hole
quencher
dabcyl
probe
molecular
beacon
mb
taqman
probe
tq
sequenc
primer
probe
primer
taqman
molecular
beacon
describ
tabl
primer
prepar
eurogentec
eurogentec
sera
belgium
probe
synthes
biolegio
biolegio
malden
netherland
multiplex
pcr
set
individu
assay
optimis
determin
optimum
mg
anneal
temperatur
primer
probe
concentr
multiplex
rnapcr
qiagen
onestep
rtpcr
kit
qiagen
hilden
germani
use
reaction
perform
l
reaction
mixtur
consist
l
qiagen
onestep
rtpcr
buffer
mm
dntp
mm
mgcl
primer
hmpv
primer
hrv
eav
molecular
beacon
hmpv
taqman
probe
hrv
molecular
beacon
eav
addit
l
templat
pcr
thermal
profil
consist
initi
cdna
step
min
c
follow
min
c
cycl
c
c
c
amplif
detect
data
analysi
perform
icycl
iq
realtim
detect
system
biorad
veenenda
netherland
hmpv
posit
patient
pcr
product
size
approxim
bp
subject
nucleotid
sequenc
analysi
determin
hmpv
subtyp
analysi
carri
abi
prism
genet
analys
use
big
dye
termin
kit
appli
biosystem
nieuwerkerk
ad
ijssel
netherland
analyt
sensit
multiplex
pcr
determin
tcid
hmpv
hrv
cycl
threshold
valu
obtain
multiplex
analys
compar
individu
pcr
differ
sensit
achiev
shown
tabl
specif
test
multiplex
pcr
show
respiratori
pathogen
amplifi
assay
except
enterovirus
high
titr
enteroviru
stock
tcid
result
weak
amplif
ct
hrv
assay
analys
pcr
product
hmpv
individu
rnapcr
agaros
gel
nonspecif
band
amplifi
well
shown
fig
thu
specif
reaction
confer
hybridis
molecular
beacon
pcrproduct
approxim
size
bp
analys
sequenc
analysi
sampl
posit
hmpv
realtim
pcr
show
complet
match
sequenc
hmpv
isol
genbank
number
nonspecif
band
neg
realtim
pcr
appear
human
dna
varieti
chromosom
sequenc
interrun
variat
hmpv
hrv
multiplex
pcr
test
amplifi
control
tcid
separ
run
mean
ct
valu
hrv
hmpv
respect
realtim
assay
eav
spike
use
intern
control
eav
dilut
use
spike
plaqu
form
unitsml
input
l
per
extract
result
posit
result
ct
valu
effici
amplif
dilut
seri
hrv
hmpv
significantli
affect
coamplif
eav
multiplex
reaction
tabl
clinic
sampl
test
inhibitori
five
throat
wash
three
nasal
wash
specimen
collect
patient
cultur
detect
common
respiratori
virus
none
specimen
cultur
posit
hmpv
probabl
cultur
termin
day
howev
multiplex
pcr
reveal
six
patient
posit
hmpv
five
patient
children
year
old
one
patient
adult
infect
hmpv
occur
five
patient
decemb
one
patient
januari
two
patient
show
coinfect
hmpv
rsv
patient
hmpv
infect
hospitalis
fever
urti
patient
test
posit
hrv
multiplex
rtpcr
also
posit
viral
cultur
patient
posit
hrv
infect
present
children
younger
year
age
found
adult
episod
hrv
posit
detect
pcr
per
month
year
shown
fig
infect
hrv
particularli
urti
defin
coryza
rhinorrhea
cough
without
fever
without
hypoxia
chang
chest
radiograph
lrti
defin
sign
symptom
pulmonari
infect
cough
rale
wheez
dyspnea
short
breath
low
oxygen
satur
pneumonia
defin
addit
also
abnorm
chest
radiograph
infiltr
observ
patient
coinfect
cmv
b
three
patient
coinfect
rsv
present
winter
month
also
preval
summer
immunocompromis
patient
seven
patient
show
coinfect
rsv
one
adenoviru
one
two
immunocompromis
patient
initi
infect
hrv
detect
later
timepoint
infect
anoth
respiratori
viru
rsv
respect
case
hrv
detect
week
multiplex
pcr
clinic
symptom
observ
hrv
posit
patient
summaris
tabl
respiratori
symptom
observ
immunocompet
patient
immunocompromis
patient
respiratori
symptom
order
provid
techniqu
rapid
detect
hrv
hmpv
multiplex
rna
pcr
develop
intern
control
virus
caus
signific
number
acut
respiratori
viral
infect
children
found
sever
respiratori
diseas
well
assay
proven
sensit
neg
effect
multiplex
differ
probe
use
two
virus
intern
control
post
pcr
analysi
requir
multiplex
rtpcr
specif
hmpv
primer
probe
design
hrv
also
amplifi
high
input
concentr
enteroviru
subtyp
weak
signal
differenti
hrv
enterovirus
use
hybridis
probe
describ
et
al
kare
et
al
ad
specif
ev
pcr
multiplex
sequenc
whole
pcr
product
would
solv
problem
differenti
unfortun
appropri
sequenc
suitabl
realtim
pcr
discrimin
hrv
enteroviru
subtyp
avail
nijhui
et
al
howev
clinic
diagnosi
necess
discrimin
hrv
enterovirus
question
manag
therapi
issu
affect
identif
hmpv
assay
describ
van
hoogen
et
al
use
sever
studi
peret
et
al
stockton
et
al
vicent
et
al
studi
perform
rnapcr
detect
agaros
gel
electrophoresi
follow
sequenc
hybridis
confirm
hmpv
posit
sampl
clearli
primer
hmpv
l
gene
result
nonspecif
amplif
product
clinic
sampl
fig
specif
could
obtain
use
molecular
beacon
realtim
rtpcr
describ
hmpv
use
lightcycl
instrument
mackay
et
al
none
intern
control
multiplex
pcr
format
far
hrv
pcr
method
requir
postpcr
analysi
like
hybridis
agaros
gelelectrophoresi
pitkaranta
et
al
steining
et
al
blomqvist
et
al
falsey
et
al
billaud
et
al
realtim
pcr
method
describ
two
multiplex
format
describ
hrv
nest
pcr
assay
detect
gel
electrophoresi
ishibashi
real
clinic
impact
diagnosi
respiratori
virus
pathogen
hmpv
hrv
would
includ
assay
well
previous
two
tube
multiplex
influenza
influenza
b
rsv
describ
templeton
et
al
screen
assay
major
respiratori
rna
virus
except
coronavirus
result
avail
within
one
day
possibl
combin
assay
addit
intern
control
reaction
import
requisit
routin
diagnost
pcr
assay
sampl
check
qualiti
nucleic
acid
extract
inhibit
inhibit
detect
nasal
swab
throat
wash
although
bal
sputa
like
inhibitori
studi
inhibit
detect
probabl
limit
number
specimen
infect
rate
hmpv
rang
children
van
den
hoogen
et
al
boivin
et
al
stockton
et
al
vicent
et
al
studi
infect
children
compar
studi
stockton
et
al
stockton
et
al
one
reason
divers
percentag
hmpv
infect
differ
clinic
criteria
use
select
patient
differ
studi
current
studi
sampl
patient
come
hospit
request
respiratori
test
collect
includ
immunocompromis
patient
undergo
screen
regardless
symptom
hmpv
infect
occur
wintermonth
compar
found
studi
peret
et
al
stockton
et
al
vicent
et
al
although
sampl
inocul
onto
appropri
cell
hmpv
isol
infect
rate
hrv
detect
studi
hrv
infect
occur
children
younger
year
age
patient
posit
hrv
viral
cultur
multiplex
rnapcr
reveal
posit
patient
therefor
viral
cultur
diagnosi
hrv
insensit
studi
pcr
shown
superior
detect
hrv
studi
well
molecular
method
demonstr
infect
rate
high
urti
steining
et
al
blomqvist
et
al
studi
incid
hrv
infect
peak
winter
also
present
autumn
summer
immunocompromis
patient
coinfect
detect
well
twice
hmpv
found
togeth
rsv
six
time
hrv
rsv
detect
suggest
sever
rsv
infect
observ
upon
coinfect
hmpv
greensil
et
al
limit
number
obtain
signific
coinfect
uncertain
howev
futur
virus
could
routin
detect
use
multiplex
assay
result
insight
respiratori
viral
coinfect
conclus
realtim
rna
pcr
method
enabl
sensit
diagnosi
hmpv
hrv
infect
poorli
detect
cell
cultur
assay
part
molecular
full
respiratori
viral
screen
thu
increas
understand
clinic
relev
epidemiolog
pathogen
respiratori
infect
